| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | -85.6% |
| Cost of Revenue | $1.1M | -96.2% |
| R&D Expense | $2.0M | -19.9% |
| SG&A Expense | $2.6M | -88.6% |
| Operating Income | -$2.3M | +96.4% |
| Interest Expense | $3.1M | +151.0% |
| Pre-tax Income | -$2.4M | +96.2% |
| Income Tax | $58K | +0.0% |
| Net Income | $8.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84K | -34.4% |
| Current Assets | $1.7M | -42.7% |
| Total Assets | $2.1M | -69.6% |
| Current Liabilities | $34.4M | -28.4% |
| Total Liabilities | $35.3M | -30.6% |
| Stockholders' Equity | -$33.2M | +24.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | +77.3% |
| Investing Cash Flow | -$65K | +95.6% |
| Financing Cash Flow | $7.5M | -80.1% |
| +113.1% |
| EPS (Basic) | $0.12 | +100.3% |
| EPS (Diluted) | $0.12 | +100.3% |